The effect of the controlled release of basic fibroblast growth factor from ionic gelatin-based hydrogels on angiogenesis in a murine critical limb ischemic model
- 1 June 2007
- journal article
- research article
- Published by Elsevier in Biomaterials
- Vol. 28 (16) , 2646-2654
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- G‐CSF‐mobilized peripheral blood mononuclear cells from diabetic patients augment neovascularization in ischemic limbs but with impaired capabilityJournal of Thrombosis and Haemostasis, 2006
- Angiogenic effect of intramuscular administration of basic and acidic fibroblast growth factor on skeletal muscles and influence of exercise on muscle angiogenesisBritish Journal of Sports Medicine, 2005
- Injectable Biopolymers Enhance Angiogenesis after Myocardial InfarctionTissue Engineering, 2005
- Management of risk in peripheral artery disease: Recent therapeutic advancesAmerican Heart Journal, 2005
- Controlled release of EGF and bFGF from dextran hydrogels in vitro and in vivoJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2005
- Management of Peripheral Arterial DiseaseCardiology in Review, 2005
- Beyond angiogenesis: the cardioprotective potential of fibroblast growth factor-2Canadian Journal of Physiology and Pharmacology, 2004
- Denatured collagen as support for a FGF-2 delivery system: physicochemical characterizations and in vitro release kinetics and bioactivityBiomaterials, 2004
- Gelatin sheet incorporating basic fibroblast growth factor enhances sternal healing after harvesting bilateral internal thoracic arteriesThe Journal of Thoracic and Cardiovascular Surgery, 2003
- Molecular Basis of Ligand Recognition by Integrin α5β1Journal of Biological Chemistry, 2000